This book first introduces the connotation, development course, standard establishment, and prospect of clinical biological sample library in the general part, and then expounds on the overall planning, foundation construction, and guarantee, whole process construction and management, informationization construction, quality control system, standard system, and the basic technology of clinical biological sample library from two angles of management and technique. Ethical construction and related laws and regulations, and finally, in the various sections, set the director of the family system to organize a representative of major diseases, chronic diseases, and other sample library platform construction principles and content, such as cerebrovascular diseases, cardiovascular diseases, Parkinson's disease, mental illness, diabetes, chronic kidney disease, orthopedic diseases, hepatitis B and AIDS, tuberculosis, new outbreaks of infectious diseases, common malignant tumors, childhood leukemia, esophageal and precancerous lesions, gastrointestinal tumors, and gynecological tumor sample bank construction.
Part 1: An Overview of Clinical Biological Sample Database.
Chapter
1.
Definition and Development of a Clinical Biobank.
Chapter
2. The
Establishment of Standards, a Clinical Biobank Milestone.
Chapter
3.
Prospects for the Sustainable Development of Clinical Biobanks.- Part 2:
General Introduction to the Database of Clinical Biological Samples.
Chapter
4. Overall Planning for Clinical Biobanks.
Chapter
5. Constructing and
Guaranteeing an Infrastructure for Clinical Biobanks.
Chapter
6. The Whole
Period Establishment and Lifecycle Management of Clinical Samples.
Chapter
7. Establishing the Biobank Information Management System.
Chapter
8. The
Quality Control System of Clinical Biobanks.
Chapter
9. The Establishment
and Application of the Standardized System in Clinical Biobanks.
Chapter
10.
The Establishment and Application of Standard Assessment Systems of Clinical
Biobanks.
Chapter
11. Ethical Issues in the Establishment of Clinical
Biobanks.
Chapter
12. Laws and Regulations for the Construction of Clinical
BiobanksManagement and Implementation of Access to Human Genetic Resources.-
Chapter
13. Construction, Management, and Application of Applied Omics
Information in Biobanks.
Chapter
14. Integration, Mining and Analysis of
Clinical Data and Bioinformatic Data.- Part 3: Theories of Clinical
Biobanks.
Chapter
15. The Biobank for Cerebrovascular Disease.
Chapter
16.
Biobanks for Cardiovascular Disease.
Chapter
17. Biobanks for Parkinsons
Disease.
Chapter
18. Biobanks for Menta Health Disorders.
Chapter
19. The
Biobank for Diabetes Mellitus.
Chapter
20. The Biobank for Chronic Kidney
Disease.
Chapter
21. Orthopedic Disease Biobanks.
Chapter
22. Hepatitis
B-Related Liver Diseases and AIDS Biobank.
Chapter
23. The Biobank for
Tuberculosis.
Chapter
24. The Biobank of Emerging Infectious Diseases.-
Chapter
25. The Biobank for Common Malignant Tumors
Chapter.
Chapter
26.
Childhood Leukemia Biobanks.
Chapter
27. EsophagealCancer and Precancerous
Lesions Biobank.
Chapter
28. Gastrointestinal Tumor Biobanks.
Chapter
29.
Gynecological Tumor Sample Bank.- Appendix.
Prof. Wang Xiaomin, MD and PhD, Vice president of Capital Medical University, Dean of Department of Neurobiology, Capital Medical University, Director of Beijing Institute for Brain Disorders, Chief scientist of Beijing Biobank for major diseases, the Council member of the International Society for Biological and Environmental Repositories (ISBER), Chairman of China region.
Prof. Gao Hengjun, MD and PhD, Director of Shanghai National Engineering Research Center for Biochip, Director of Shanghai Molecular Medicine Engineering Technology Research Center, Director of the Institute of Digestive Diseases, Tongji University School of Medicine, Chairman of the National Committee for Standardization of Biological samples, Chairman of the Biological Sample library branch of China Pharmaceutical Biotechnology Association, professor and chief physician.
